Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
GLP-1 drugs (exenatide, liraglutide etc), as well as GIP/GLP-1 hybrid peptides (tirzepatide), are clinically approved for diabetes and/or obesity, with GLP-2 based drugs (teduglutide) approved for the treatment of short bowel syndrome
You can start your weight loss journey with confidence, knowing you have dependable support
GLP-1 users saw a 44% reduction in hospitalizations due to stroke, heart attack and heart failure compared to the control group
Click the underlined page links if you're interested in learning more about "What is Wegovy?", which is similarly referred to as Ozempic or semaglutide, or about "What is Zepbound?", which is similarly referred to as Mounjaro or tirzepatide
While both are GLP-1 receptor agonists, tirzepatide additionally targets GIP receptors, presenting advantageous results in weight loss and metabolic improvements
US$ 20.26
US$ 23.32
US$ 25.53
